Lv7
5000 积分 2023-11-15 加入
Outcomes of Older Adults With Advanced Cancer Who Prefer Quality of Life vs Prolonging Survival
3天前
已完结
Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study
7天前
已完结
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
18天前
已完结
Optimal choice of different neoadjuvant chemoradiotherapies for locally advanced rectal cancer: systematic review and network meta-analysis
22天前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
1个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
1个月前
已完结
Successful Treatment of Metastatic Colorectal Cancer with Synchronous BRAF V600E Mutation and DMMR with BGB-A317
2个月前
已完结
Upfront progression under pembrolizumab followed by a complete response after encorafenib and cetuximab treatment in BRAF V600E‐mutated and microsatellite unstable metastatic colorectal cancer patient: A case report
2个月前
已完结
Successful Treatment of Metastatic Colorectal Cancer with Synchronous BRAF V600E Mutation and DMMR with BGB-A317
2个月前
已关闭
Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitors
2个月前
已完结
皖公网安备34019202002308
